The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Kuhlik
B N
BN
Covington & Burling, Washington, D.C., USA.
D000329:Advertising; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling; D005569:Formularies as Topic; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D008329:Managed Care Programs / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D010593:Pharmaceutical Services / Q000331:legislation & jurisprudence / Q000458:organization & administration; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence* / Q000592:standards